The Mycobacterium tuberculosis Beijing genotype does not affect tuberculosis treatment failure in Vietnam

Clinical Infectious Diseases

Volumn 51, Issue 8, 2010, Pages 879-886

  Buu, Tran N ^a,d   Huyen, Mai N T ^a   Van Soolingen, Dick ^b   Lan, Nguyen T N ^a   Quy, Hoang T ^a   Tiemersma, Edine W ^c   Borgdorff, Martien W ^d   Cobelens, Frank G J ^d  

^a Pham Ngoc Thach Hospital   (Viet Nam)

^b NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

^c KNCV TUBERCULOSIS FOUNDATION   (Netherlands)

^d ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; ETHAMBUTOL; ISONIAZID; PYRAZINAMIDE; RIFAMPICIN; STREPTOMYCIN;

ADULT; AGED; ANTIBIOTIC SENSITIVITY; ARTICLE; BEIJING GENOTYPE; CONTROLLED STUDY; DNA FINGERPRINTING; DRUG TREATMENT FAILURE; FEMALE; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIDRUG RESISTANCE; MULTIDRUG RESISTANT TUBERCULOSIS; MYCOBACTERIUM TUBERCULOSIS; PATIENT COMPLIANCE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RURAL AREA; SPUTUM CULTURE; VARIABLE NUMBER OF TANDEM REPEAT; VIET NAM;

ADOLESCENT; ADULT; AGED; ANTITUBERCULAR AGENTS; BACTERIAL TYPING TECHNIQUES; DNA FINGERPRINTING; DRUG RESISTANCE, MULTIPLE, BACTERIAL; FEMALE; GENOTYPE; HUMANS; INCIDENCE; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; MYCOBACTERIUM TUBERCULOSIS; PROSPECTIVE STUDIES; RURAL POPULATION; TREATMENT FAILURE; TUBERCULOSIS; VIETNAM; YOUNG ADULT;

EID: 77957830867     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/656410     Document Type: Article

References (40)

1. Dye C. Global epidemiology of tuberculosis. Lancet 2006; 367:938-939.
2. Amnuaiphon W, Anuwatnonthakate A, Nuyongphak P, et al. Factors associated with death among HIV-uninfected TB patients in Thailand, 2004-2006. Trop Med Int Health 2009; 14:1338-1346.
3. Singla R, Srinath D, Gupta S, et al. Risk factors for new pulmonary tuberculosis patients failing treatment under the Revised National Tuberculosis Control Programme, India. Int J Tuberc Lung Dis 2009; 13: 521-526.
4. Quy HT, Cobelens FG, Lan NT, Buu TN, Lambregts CS, Borgdorff MW. Treatment outcomes by drug resistance and HIV status among tuberculosis patients in Ho Chi Minh City, Vietnam. Int J Tuberc Lung Dis 2006; 10:45-51. (Pubitemid 43266276)
5. Kwon YS, Kim YH, Suh GY, et al. Treatment outcomes for HIV-uninfected patients with multidrug-resistant and extensively drug-resistant tuberculosis. Clin Infect Dis 2008; 47:496-502.
6. Masjedi MR, Tabarsi P, Chitsaz E, et al. Outcome of treatment of MDR-TB patients with standardised regimens, Iran, 2002-2006. Int J Tuberc Lung Dis 2008; 12:750-755.
7. Ferrara G, Richeldi L, Bugiani M, et al. Management of multidrug-resistant tuberculosis in Italy. Int J Tuberc Lung Dis 2005; 9:507-513.
8. World Health Organization. Multidrug and extensively drug-resistant TB (M/XDR-TB): 2010 global report on surveillance and response. Geneva, Switzerland: World Health Organization, 2010.
9. Anh DD, Borgdorff MW, Van LN, et al. Mycobacterium tuberculosis Beijing genotype emerging in Vietnam. Emerg Infect Dis 2000; 6:302-305.
10. Borgdorff MW, de Haas P, Kremer K, van Soolingen D. Mycobacterium tuberculosis Beijing genotype, the Netherlands. Emerg Infect Dis 2003;9: 1310-1313.
11. Jou R, Chiang CY, Huang WL. Distribution of the Beijing family genotypes of M. tuberculosis in Taiwan. J Clin Microbiol 2005; 43:95-100.
12. van Crevel R, Nelwan RH, de Lenne W, et al. Mycobacterium tuberculosis Beijing genotype strains associated with febrile response to treatment. Emerg Infect Dis 2001; 7:880-883.
13. Cox HS, Kubica T, Doshetov D, Kebede Y, Rüsch-Gerdess S, Niemann S. The Beijing genotype and drug resistant tuberculosis in the Aral Sea region of Central Asia. Respir Res 2005; 6:134. (Pubitemid 41645674)
14. Almeida D, Rodrigues C, Ashavaid TF, Lalvani A, Udwadia ZF, Mehta A. High incidence of the Beijing genotype among multidrug-resistant isolates of M. tuberculosis in a tertiary care center in Mumbai, India. Clin Infect Dis 2005; 40:881-886.
15. Balabanova Y, Drobniewski F, Fedorin I, et al. The direct observed therapy short course (DOTS) strategy in Samara Oblast, Russian Federation. Respir Res 2006; 7:44.
16. Sun YJ, Lee AS, Wong SY, et al. Genotype and phenotype relationships and transmission analysis of drug-resistant tuberculosis in Singapore. Int J Tuberc Lung Dis 2007; 11:436-442.
17. Buu TN, Huyen MN, Lan NT, et al. The Beijing genotype is associated with young age and multidrug-resistant tuberculosis in rural Vietnam. Int J Tuberc Lung Dis 2009; 13:900-906.
18. Cox HS, Niemann S, Ismailov G, et al. Risk of acquired drug resistance during short-course directly observed treatment of tuberculosis in an area with high levels of drug resistance. Clin Infect Dis 2007; 44:1421-1437. (Pubitemid 46801583)
19. World Health Organization. Treatment of tuberculosis: guidelines for national programmes. 3rd ed. Geneva, Switzerland: World Health Organization, 2003.
20. International Union against Tuberculosis and Lung Disease. Technical guide: sputum examination for tuberculosis direct microscopy in low income countries. 5th ed. Paris, France: The Union, 2000.
21. Huong NT, Duong BD, Co NV, et al. Establishment and development of the National Tuberculosis Control Programme in Vietnam. Int J Tuberc Lung Dis 2005; 9:151-156. (Pubitemid 40278376)
22. World Health Organization. Guidelines for surveillance of drug resistance in tuberculosis. 2nd ed. Geneva, Switzerland: World Health Organization, 2003.
23. Kamerbeek J, Schouls L, Kolk A, et al. Simultaneous detection and strain differentiation of Mycobacterium tuberculosis for diagnosis and epidemiology. J Clin Microbiol 1997; 35:907-914.
24. Instistute de Biologie-Instistute Pateur the Lille. Multilocus variable number tandem repeat genotyping of Mycobacterium tuberculosis: technical guide. Lille, France: Institut Pasteur, 2005.
25. Kremer K, Glynn JR, Lillebaek T, et al. Definition of the Beijing/W lineage of M. tuberculosis on the basis of genetic markers. J Clin Microbiol 2004; 42:4040-4049.
26. Brudey K, Driscoll JR, Rigouts L, et al. Mycobacterium tuberculosis complex genetic diversity: mining the fourth international spoligotyping database (SpolDB4) for classification, population genetics and epidemiology. BMC Microbiol 2006; 6:23.
27. Supply P, Allix C, Lesjean S, et al. Proposal for standardization of optimized mycobacterial interspersed repetitive unit-variable-number tandem repeat typing of Mycobacterium tuberculosis. J Clin Microbiol 2006; 44:4498-4410.
28. Feng JY, Su WJ, Tsai CC, Chang SC. Clinical impact of Mycobacterium tuberculosis W-Beijing genotype strain infection on aged patients in Taiwan. J Clin Microbiol 2008; 46:3127-3129.
29. Lan NT, Lien HT, Tung LB, Borgdorff MW, Kremer K, van Soolingen D. Mycobacterium tuberculosis Beijing genotype and risk for treatment failure and relapse, Vietnam. Emerg Infect Dis 2003; 9:1633-1635.
30. Parwati I, van Crevel R, Sudiro M, et al. Mycobacterium tuberculosis population structures differ significantly on two Indonesian Islands. J Clin Microbiol 2008; 46:3639-3645.
31. Parwati I, Alisjahbana B, Apriani L, et al. Mycobacterium tuberculosis Beijing genotype is an independent risk factor for tuberculosis treatment failure in Indonesia. J Infect Dis 2010; 201:553-557.
32. Lew W, Pai M, Oxlade O, Martin D, Menzies D. Initial drug resistance and tuberculosis treatment outcomes: systematic review and meta-analysis. Ann Intern Med 2008; 149:123-134. (Pubitemid 352008599)
33. Quy HT, Lan NT, Borgdorff MW, et al. Drug resistance among failure and relapse cases of tuberculosis: is the standard re-treatment regimen adequate? Int J Tuberc Lung Dis 2003; 7:631-636.
34. Lönnroth K, Thuong LM, Lambregts K, Quy HT, Diwan VK. Private tuberculosis care provision associated with poor treatment outcome: comparative study of a semi-private lung clinic and the NTP in two urban districts in Ho Chi Minh City, Vietnam. National Tuberculosis Programme. Int J Tuberc Lung Dis 2003; 7:165-171. (Pubitemid 36172678)
35. Warren RM, Victor TC, Streicher EM, et al. Patients with active tuberculosis often have different strains in the same sputum specimen. Am J Respir Crit Care Med 2004; 169:610-614.
36. Wang JY, Lee LN, Lai HC, et al. Prediction of the tuberculosis reinfection proportion from the local incidence. J Infect Dis 2007; 196: 281-288.
37. Verver S, Warren RM, Beyers N, et al. Rate of reinfection tuberculosis after successful treatment is higher than rate of new tuberculosis. Am J Respir Crit Care Med 2005; 171:1430-1435. (Pubitemid 40800517)
38. Caws M, Thwaites G, Stepniewska K, et al. Beijing genotype of Mycobacterium tuberculosis is significantly associated with human immunodeficiency virus infection and multidrug resistance in cases of tuberculous meningitis. J Clin Microbiol 2006; 44:3934-3939.
39. Havlir DV, Barnes PF. Tuberculosis in patients with human immunodeficiency virus infection. N Engl J Med 1999; 340:367-373.
40. White E. The effect of misclassification of disease status in follow-up studies: implications for selecting disease classifiaction criteria. Am J Epidemiol 1986; 124:816-825. (Pubitemid 17180496)